Preparation method of artemisia annua fermented product with soothing, oil-controlling and antibacterial effects, and its product and application
Through the multiple fermentation of Bifidobacter brevis, Saccharomyces cerevisiae and Bacillus subtilis, the problem of insufficient application of Artemisia annua fermentation products in the cosmetics field is solved, and the preparation of Artemisia annua fermentation products with the effect of soothing, controlling and antibacterial effects is achieved, which significantly improves the resistance of Artemisia annua Oxidation and antibacterial effects.
Patent Information
- Application Number
- CN202411179080.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-27
AI Technical Summary
In the prior art, the fermentation and extraction products of Artemisia annua have not been effectively utilized in the cosmetics field, and there is a lack of products that have the effect of soothing, controlling, and antibacterial effects.
Multiple fermentation is carried out by Bifidobacter bream, Saccharomyces cerevisiae and Bacillus subtilis. By fermenting Artemisia annua and Artemisia sago, products with antioxidant, soothing sensitivity, oil-control, anti-inflammatory and antibacterial effects are produced, and the loss of active ingredients during the extraction process is avoided. .
It achieves the significant antioxidant, soothing, oil-control and antibacterial effects of the fermentation products of Artemisia annua, maintains the natural active ingredients of the plant, and is better than the mixed fermentation effect of single-step fermentation and lacks a certain Chinese medicine.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of material extraction, and relates to a preparation method of an artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects, and a product and application thereof. Background Art
[0002] As a traditional Chinese medicine, Artemisia annua was first seen in "Wu Er Bing Fang" and later included in many herbal classics. It is widely distributed in Chongqing, Anhui, Hubei, Shandong and other places in my country. Artemisia annua is mainly used to treat fever and cold as a traditional Chinese medicine. It is recorded in "Shennong Baicao Jing", "Zhou Hou Bei Ji Fang" and "Compendium of Materia Medica". Artemisia annua has the effects of clearing heat and detoxifying, cooling blood, and strengthening the stomach. It contains a variety of biologically active ingredients such as flavonoids, polysaccharides, polyphenols, and volatile oils.
[0003] Artemisia annua fermentation is mostly used in the field of food and health products, and its fermentation extracts have not yet been used in the field of cosmetics. After fermentation, plants will produce active substances with significant skin care effects. my country has rich Chinese herbal medicine resources, and many studies have reported that cosmetic raw materials with significant skin care effects are obtained through microbial fermentation of Chinese herbal medicines. However, research on the fermentation and utilization of Artemisia annua is relatively limited. Summary of the invention
[0004] In view of the deficiencies in the prior art, the object of the present invention is to provide a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, as well as a product and application thereof.
[0005] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0006] In a first aspect, the present invention provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, the preparation method comprising:
[0007] (1) inoculating a culture medium containing Artemisia annua with a bacterial solution of Bifidobacterium breve and a bacterial solution of Saccharomyces cerevisiae for fermentation to obtain a first fermentation product;
[0008] (2) sterilizing the first fermentation product, cooling it, inoculating it with a Bacillus subtilis liquid, and fermenting it to obtain a second fermentation product;
[0009] (3) Centrifuge the second fermentation product and sterilize it.
[0010] The present invention adopts multiple fermentation, i.e., bifidobacterium breve, saccharomyces cerevisiae and bacillus subtilis for fermentation, does not add any organic reagent, has mild fermentation conditions, maintains the natural activity of plants, and avoids the loss of active ingredients caused by the extraction method. Bifidobacterium breve and saccharomyces cerevisiae have a mutual cooperation effect, and the effect of using the two strains for fermentation at the same time is better.
[0011] The fermentation of Artemisia annua and Artemisia annua by Bifidobacterium breve helps the production of artemisinic acid, organic acids and the enrichment of polysaccharides, and has a synergistic effect with the probiotic fermentation product components in the fermentation filtrate. At the same time, the endophytic bacterium Bacillus subtilis is used for secondary fermentation, which has significant antioxidant, sensitivity relief, oil control, anti-inflammatory and antibacterial effects.
[0012] Preferably, the method for preparing the culture medium containing Artemisia annua comprises:
[0013] (1) Crush 3-5 parts of Artemisia annua, 1-3 parts of Artemisia annua, 1-2 parts of Portulaca oleracea, and 1-2 parts of Sophora flavescens, mix and grind with 10-15 parts of water to obtain a slurry;
[0014] (2) hydrolyzing the slurry to obtain an enzymatic hydrolyzate;
[0015] (3) Mix the enzymatic hydrolysate with 0.2-2.5 parts of a carbon source, 0.05-0.1 parts of an inorganic salt, 0.5-1 parts of inulin and 70-80 parts of water, and sterilize to obtain the product.
[0016] The mass proportion of the Artemisia annua can be 3 parts, 3.2 parts, 3.4 parts, 3.6 parts, 3.8 parts, 4 parts, 4.2 parts, 4.4 parts, 4.6 parts, 4.8 parts, 5 parts, etc., the mass proportion of Artemisia annua can be 1 part, 1.2 parts, 1.4 parts, 1.6 parts, 1.8 parts, 2 parts, 2.2 parts, 2.4 parts, 2.6 parts, 2.8 parts, 3 parts, etc., the mass proportion of Portulaca oleracea can be 1 The mass fractions of Sophora flavescens can be selected from 1 part, 1.1 parts, 1.2 parts, 1.3 parts, 1.4 parts, 1.5 parts, 1.6 parts, 1.7 parts, 1.8 parts, 1.9 parts, 2 parts, etc. The mass fractions of water in step (1) can be selected from 10 parts, 11 parts, The mass fraction of the carbon source can be 0.2 parts, 0.5 parts, 0.8 parts, 1 parts, 1.2 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.5 parts, etc. The mass fraction of the inorganic salt can be 0.05 parts, 0.06 parts, 0.07 parts, 0.08 parts, 0.09 parts, 0.1 parts, etc. The mass fraction of inulin can be 0.5 parts , 0.55 parts, 0.6 parts, 0.65 parts, 0.7 parts, 0.75 parts, 0.8 parts, 0.85 parts, 0.9 parts, 0.95 parts, 1 parts, etc., the mass fraction of water can be selected as 70 parts, 71 parts, 72 parts, 73 parts, 74 parts, 75 parts, 76 parts, 77 parts, 78 parts, 79 parts, 80 parts, etc., and other specific point values within the above numerical range can be selected, so they will not be described here one by one.
[0017] The present invention creatively discovered that Artemisia annua, Artemisia annua, Portulaca oleracea, and Sophora flavescens have a potential synergistic effect in improving the soothing, oil-controlling, and antibacterial effects of fermented products. Without any one of them, the effect is not good.
[0018] Preferably, the carbon source includes mannitol, and the inorganic salt includes potassium dihydrogen phosphate and magnesium sulfate.
[0019] The present invention finds that when mannitol is used as a carbon source, the effect is better than other carbon sources.
[0020] Preferably, the temperature of mixing with the enzyme is 40-50° C. and the time is 1-2 h.
[0021] The temperature can be selected as 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C, etc., and the time can be selected as 1 h, 1.1 h, 1.2 h, 1.3 h, 1.4 h, 1.5 h, 1.6 h, 1.7 h, 1.8 h, 1.9 h, 2h, etc. Other specific point values within the above numerical range can be selected, so they will not be described one by one here.
[0022] Preferably, the added amount of the enzyme is 50000-100000 U / g, for example, 50000 U / g, 55000 U / g, 60000 U / g, 65000 U / g, 70000 U / g, 75000 U / g, 80000 U / g, 85000 U / g, 90000 U / g, 95000 U / g, 100000 U / g, etc. Other specific points within the above numerical range can be selected, which will not be repeated here.
[0023] Preferably, the enzyme comprises any one of cellulase, pectinase or protease, or a combination of at least two of them.
[0024] Preferably, the enzyme is a combination of cellulase, pectinase and protease.
[0025] Preferably, the enzyme activity ratio of the cellulase, pectinase and protease is (2-3):(1-2):(1-2).
[0026] Among them, the specific point values in (2-3) can be selected as 2, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3, etc., and the specific point values in (1-2) can be selected as 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, etc. Other specific point values within the above numerical range can be selected, and they will not be listed here one by one.
[0027] Preferably, the culture medium is sterilized at a temperature of 115-121° C. for 15-20 min.
[0028] The temperature can be selected as 115°C, 116°C, 117°C, 118°C, 119°C, 120°C, 121°C, etc., and the time can be selected as 15 min, 16 min, 17 min, 18 min, 19 min, 20 min, etc. Other specific point values within the above numerical range can be selected, and they will not be described here one by one.
[0029] Preferably, the pH of the culture medium containing Artemisia annua is 6-7, for example 6, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7, etc. Other specific points within the above numerical range can be selected and will not be described here one by one.
[0030] Preferably, the viable count of the brewer's yeast solution is (1×10 6 ) CFU / mL-(5×10 6 ) CFU / mL, and the inoculum size was 3-5%.
[0031] The viable count can be selected as 1×10 6 CFU / mL, 1.2×10 6 CFU / mL, 1.5×10 6 CFU / mL, 1.8×10 6 CFU / mL, 2×10 6 CFU / mL, 2.2×10 6 CFU / mL, 2.5×10 6 CFU / mL, 2.8×10 6 CFU / mL, 3×10 6 CFU / mL, 3.2×10 6 CFU / mL, 3.5×10 6 CFU / mL, 3.8×10 6 CFU / mL, 4×10 6 CFU / mL, 4.2×10 6 CFU / mL, 4.5×10 6 CFU / mL, 4.8×10 6 CFU / mL, 5×10 6 CFU / mL, etc. The inoculation amount can be selected as 3%, 3.2%, 3.4%, 3.6%, 3.8%, 4%, 4.2%, 4.4%, 4.6%, 4.8%, 5%, etc. Other specific point values within the above numerical range can be selected, so they will not be elaborated here.
[0032] Preferably, the viable bacterial count of the Bifidobacterium breve bacterial solution is (1×10 6 ) CFU / mL-(5×10 6 ) CFU / mL, and the inoculum size was 3-5%.
[0033] The viable count can be selected as 1×10 6 CFU / mL, 1.2×10 6 CFU / mL, 1.5×10 6 CFU / mL, 1.8×10 6 CFU / mL, 2×10 6 CFU / mL, 2.2×10 6 CFU / mL, 2.5×10 6 CFU / mL, 2.8×10 6 CFU / mL, 3×10 6 CFU / mL, 3.2×10 6 CFU / mL, 3.5×10 6 CFU / mL, 3.8×10 6 CFU / mL, 4×10 6 CFU / mL, 4.2×10 6 CFU / mL, 4.5×10 6 CFU / mL, 4.8×10 6 CFU / mL, 5×10 6 CFU / mL, etc. The inoculation amount can be selected as 3%, 3.2%, 3.4%, 3.6%, 3.8%, 4%, 4.2%, 4.4%, 4.6%, 4.8%, 5%, etc. Other specific point values within the above numerical range can be selected, so they will not be elaborated here.
[0034] Preferably, the viable bacterial count of the Bacillus subtilis liquid is (1×10 7 ) CFU / mL-(5×10 7 ) CFU / mL, and the inoculum size was 2-4%.
[0035] The viable count can be selected as 1×10 7 CFU / mL, 1.2×10 7 CFU / mL, 1.5×10 7 CFU / mL, 1.8×10 7 CFU / mL, 2×10 7 CFU / mL, 2.2×10 7 CFU / mL, 2.5×10 7 CFU / mL, 2.8×10 7CFU / mL, 3×10 7 CFU / mL, 3.2×10 7 CFU / mL, 3.5×10 7 CFU / mL, 3.8×10 7 CFU / mL, 4×10 7 CFU / mL, 4.2×10 7 CFU / mL, 4.5×10 7 CFU / mL, 4.8×10 7 CFU / mL, 5×10 7 CFU / mL, etc. The inoculation amount can be selected as 2%, 2.2%, 2.4%, 2.6%, 2.8%, 3%, 3.2%, 3.4%, 3.6%, 3.8%, 4%, etc. Other specific point values within the above numerical range can be selected, so they will not be elaborated here.
[0036] Preferably, in step (1), the fermentation temperature is 30-35°C, the fermentation time is 12-16 h, and the pH is 5-6.
[0037] The temperature can be selected from 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, etc., the time can be selected from 12 h, 12.5 h, 13 h, 13.5 h, 14 h, 14.5 h, 15 h, 15.5 h, 16 h, etc., and the pH can be selected from 5, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6, etc. Other specific point values within the above numerical range can be selected, so they will not be described one by one here.
[0038] Preferably, step (1) is fermented under anaerobic conditions.
[0039] Preferably, the fermentation in step (1) is carried out under stirring conditions, and the stirring speed is 60-100 rpm, for example, 60 rpm, 65 rpm, 70 rpm, 75 rpm, 80 rpm, 85 rpm, 90 rpm, 95 rpm, 100 rpm, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0040] Preferably, the sterilization temperature in step (2) is 80-85°C and the time is 15-20 min.
[0041] The temperature can be selected from 80°C, 80.5°C, 81°C, 81.5°C, 82°C, 82.5°C, 83°C, 83.5°C, 84°C, 84.5°C, 85°C, etc., and the time can be selected from 15 min, 16 min, 17 min, 18 min, 19 min, 20 min, etc. Other specific point values within the above numerical range can be selected, and they will not be elaborated here.
[0042] Preferably, in step (2), the fermentation temperature is 35-36°C, the fermentation time is 20-28 h, and the pH is 6-6.5.
[0043] The temperature can be selected as 35°C, 35.2°C, 35.4°C, 35.6°C, 35.8°C, 36°C, etc., the time can be selected as 20 h, 21 h, 22 h, 23 h, 24 h, 25 h, 26 h, 27 h, 28 h, etc., the pH is 6.1, 6.2, 6.3, 6.4, 6.5, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0044] Preferably, in step (2), air is introduced during the fermentation process at a ventilation rate of 10-20 m 3 / h, for example 10 m 3 / h、11m 3 / h, 12 m 3 / h、13 m 3 / h, 14 m 3 / h, 15 m 3 / h, 16 m 3 / h, 17 m 3 / h、18 m 3 / h、19 m 3 / h, 20 m 3 / h, etc. Other specific point values within the above numerical range can be selected and will not be described here one by one.
[0045] Preferably, the centrifugation speed in step (3) is 8000-10000 rpm and the time is 4-6 min.
[0046] The rotation speed can be selected as 8000 rpm, 8200 rpm, 8400 rpm, 8600 rpm, 8800 rpm, 9000 rpm, 9200 rpm, 9400 rpm, 9600 rpm, 9800 rpm, 10000 rpm, etc., and the time can be selected as 4 min, 4.2 min, 4.4 min, 4.6 min, 4.8 min, 5 min, 5.2 min, 5.4 min, 5.6 min, 5.8 min, 6 min, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0047] Preferably, the sterilization method is filtration sterilization.
[0048] In a second aspect, the present invention provides an Artemisia annua fermented product prepared according to the method for preparing the Artemisia annua fermented product with soothing, oil-controlling and antibacterial effects described in the first aspect.
[0049] In a third aspect, the present invention provides a use of the Artemisia annua fermentation product according to the second aspect in the preparation of cosmetics.
[0050] Preferably, the added amount of the Artemisia annua fermentation product in the cosmetic is 1-3% of the mass of the cosmetic, for example 1%, 1.2%, 1.4%, 1.6%, 1.8%, 2%, 2.2%, 2.4%, 2.6%, 2.8%, 3%, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0051] Compared with the prior art, the present invention has the following beneficial effects:
[0052] The invention adopts multiple fermentation, namely, adopts Bifidobacterium breve, Saccharomyces cerevisiae and Bacillus subtilis for fermentation, does not add any organic reagent, has mild fermentation conditions, maintains the natural activity of plants, and avoids the loss of active ingredients caused by the extraction method.
[0053] The fermentation of Artemisia annua and Artemisia annua by Bifidobacterium breve helps the production of artemisinic acid, organic acids and the enrichment of polysaccharides, and has a synergistic effect with the probiotic fermentation product components in the fermentation filtrate. At the same time, the endophytic bacterium Bacillus subtilis is used for secondary fermentation, which has significant antioxidant, sensitivity relief, oil control, anti-inflammatory and antibacterial effects. DETAILED DESCRIPTION
[0054] In order to further explain the technical means and effects adopted by the present invention, the technical solution of the present invention is further described below in conjunction with the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
[0055] The sources of the functional ingredients contained in the products involved in the following embodiments and comparative examples are as follows (only the functional ingredients are reflected, and the necessary auxiliary ingredients contained in other commercially available raw materials are not repeated):
[0056] Inulin was purchased from Shandong Bailong Chuangyuan Biotechnology Co., Ltd. under the trade name of Inulin;
[0057] Cellulase was purchased from Henan Feishi Biotechnology Co., Ltd. under the trade name of Cellulase;
[0058] Pectinase was purchased from Henan Feishi Biotechnology Co., Ltd. under the trade name of Pectinase;
[0059] Protease was purchased from Henan Feishi Biotechnology Co., Ltd. under the trade name of protease;
[0060] Sucrose was purchased from Zhengzhou Guangyu Food Additive Co., Ltd. under the trade name of Sucrose.
[0061] The brewing yeast Saccharomyces cerevisiae YK-S001 strain involved in the following content is classified and named as brewing yeast Saccharomyces cerevisiae, the preservation number is CGMCC No.28276, the preservation date is August 28, 2023, the preservation unit is the General Microbiology Center of China Culture Collection Administration, and the preservation address is No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing.
[0062] Preparation Example 1
[0063] This preparation example provides a method for preparing a bacterial liquid, the preparation method comprising:
[0064] Bifidobacterium breve and Bacillus subtilis were inoculated into MRS medium, cultured and subcultured for 3 times, with each culture lasting 10 hours.
[0065] Preparation Example 2
[0066] This preparation example provides a method for preparing a fungal liquid, the preparation method comprising:
[0067] The brewer's yeast was inoculated into YPD medium and cultured for 3 times, with each culture lasting 12 h.
[0068] Example 1
[0069] This embodiment provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, the preparation method comprising:
[0070] (1) grinding a Chinese medicine composition into powder, wherein the Chinese medicine composition comprises 4 parts of Artemisia annua, 2 parts of Artemisia annua, 1 part of Portulaca oleracea, and 1 part of Sophora flavescens, adding 15 parts of water, and grinding using a colloid mill to obtain a slurry;
[0071] (2) heating the slurry to 45° C. and adding enzymes for hydrolysis for 1.5 h, wherein the enzymes are a combination of cellulase, pectinase, and protease with an enzyme activity ratio of 3:1:1 and a total enzyme activity of 80,000 U / g, to obtain an enzymatic hydrolyzate;
[0072] (3) Mix the enzymatic hydrolyzate with 80 parts of water, 1.5 parts of mannitol, 0.8 parts of inulin, 0.04 parts of magnesium sulfate, and 0.04 parts of potassium dihydrogen phosphate, adjust the pH to about 6.5, and sterilize at 121° C. for 20 minutes to prepare a fermentation medium;
[0073] (4) Inoculate 4% of Bifidobacterium breve ATCC 15700 culture medium (viable count 3×10 6 CFU / mL) and 4% Saccharomyces cerevisiae YK-S001 solution (viable count 3×10 6 CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, and fermentation was carried out at 34°C and 80 rpm for 14 h. The pH was adjusted to 5.5 to obtain the first fermentation product.
[0074] (5) The first fermentation product was sterilized at 85°C for 20 min, the pH was adjusted to 6.2, and 3% Bacillus subtilis ATCC6633 culture solution (viable cell count was 3×10 7 CFU / mL), at 35°C, with a ventilation volume of 15 m 3 / h for 24 h to obtain the second fermentation product;
[0075] (6) The obtained product was centrifuged at 9000 rpm for 5 min, and the supernatant was sterilized by filtering through 0.22 μm.
[0076] Example 2
[0077] This embodiment provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, the preparation method comprising:
[0078] (1) grinding a Chinese medicine composition into powder, wherein the Chinese medicine composition comprises 3 parts of Artemisia annua, 3 parts of Artemisia annua, 2 parts of Portulaca oleracea, and 2 parts of Sophora flavescens, adding 13 parts of water, and grinding using a colloid mill to obtain a slurry;
[0079] (2) heating the slurry to 40° C. and adding enzymes for hydrolysis for 2 h, wherein the enzymes are a combination of cellulase, pectinase, and protease with an enzyme activity ratio of 3:2:2 and a total enzyme activity of 50,000 U / g, to obtain an enzymatic hydrolyzate;
[0080] (3) Mix the enzymatic hydrolyzate with 75 parts of water, 2.5 parts of mannitol, 0.5 parts of inulin, 0.05 parts of magnesium sulfate, and 0.05 parts of potassium dihydrogen phosphate, adjust the pH to about 6, and sterilize at 115° C. for 20 minutes to prepare a fermentation medium;
[0081] (4) Inoculate the fermentation medium with 5% of Bifidobacterium breve ATCC 15700 culture medium (viable cell count 1×10 6 CFU / mL) and 5% Saccharomyces cerevisiae YK-S001 bacterial solution (viable count 1×10 6 CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, and fermentation was carried out at 30°C and 60 rpm for 16 h. The pH was adjusted to 5 to obtain the first fermentation product.
[0082] (5) The first fermentation product was sterilized at 80°C for 20 min, the pH was adjusted to 6, and 4% Bacillus subtilis ATCC6633 culture solution (the number of viable cells was 1×10 7 CFU / mL), at 36°C, with a ventilation volume of 10 m 3 / h for 20 h to obtain the second fermentation product;
[0083] (6) The obtained product was centrifuged at 10,000 rpm for 4 min, and the supernatant was sterilized by filtering through 0.22 μm.
[0084] Example 3
[0085] This embodiment provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, the preparation method comprising:
[0086] (1) grinding a Chinese medicine composition into powder, wherein the Chinese medicine composition comprises 5 parts of Artemisia annua, 1 part of Artemisia annua, 1.5 parts of Portulaca oleracea, and 1.5 parts of Sophora flavescens, adding 10 parts of water, and grinding using a colloid mill to obtain a slurry;
[0087] (2) heating the slurry to 50° C. and adding enzymes for hydrolysis for 1 h, wherein the enzymes are a combination of cellulase, pectinase, and protease with an enzyme activity ratio of 1:1:1 and a total enzyme activity of 100,000 U / g, to obtain an enzymatic hydrolyzate;
[0088] (3) Mix the enzymatic hydrolyzate with 70 parts of water, 0.5 parts of mannitol, 1 part of inulin, 0.03 parts of magnesium sulfate, and 0.03 parts of potassium dihydrogen phosphate, adjust the pH to about 7, and sterilize at 118°C for 20 minutes to prepare a fermentation medium;
[0089] (4) Inoculate 3% of Bifidobacterium breve ATCC 15700 culture medium (viable count 5×10 6 CFU / mL) and 3% Saccharomyces cerevisiae YK-S001 bacterial solution (viable count 5×10 6CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, and fermentation was carried out at 35°C and 100 rpm for 12 h. The pH was adjusted to 6 to obtain the first fermentation product.
[0090] (5) The first fermentation product was sterilized at 85°C for 15 min, the pH was adjusted to 6.5, and 1% Bacillus subtilis ATCC6633 culture solution (the number of viable cells was 5×10 7 CFU / mL), at 35°C, with a ventilation volume of 20 m 3 / h for 28 h to obtain the second fermentation product;
[0091] (6) The obtained product was centrifuged at 8000 rpm for 6 min, and the supernatant was sterilized by filtering through 0.22 μm.
[0092] Example 4
[0093] This embodiment provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The only difference between the method and embodiment 1 is that the Chinese medicine composition in step (1) does not contain Artemisia annua, and its reduced mass is proportionally distributed to the mass of Artemisia annua, Portulaca oleracea and Sophora flavescens, and other operations remain unchanged.
[0094] Example 5
[0095] This embodiment provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The only difference between the method and embodiment 1 is that the Chinese medicine composition in step (1) does not contain Artemisia annua, and its reduced mass is proportionally distributed to the mass of Artemisia annua, Portulaca oleracea and Sophora flavescens, and other operations remain unchanged.
[0096] Example 6
[0097] This embodiment provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The only difference between this method and Embodiment 1 is that the Chinese medicine composition in step (1) does not contain Portulaca oleracea, and its reduced mass is proportionally distributed to the mass of Artemisia annua, Artemisia annua and Sophora flavescens, and other operations remain unchanged.
[0098] Example 7
[0099] This embodiment provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The only difference between this method and Embodiment 1 is that the Chinese medicine composition in step (1) does not contain Sophora flavescens, and its reduced mass is proportionally distributed to the mass of Artemisia annua, Artemisia annua and Portulaca oleracea, and other operations remain unchanged.
[0100] Example 8
[0101] This embodiment provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The method is different from Embodiment 1 only in that in step (3), mannitol is replaced by maltose in an equal amount, and other operations remain unchanged.
[0102] Example 9
[0103] This embodiment provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects. The method is different from Embodiment 1 only in that in step (3), mannitol is replaced by glucose in an equal amount, and other operations remain unchanged.
[0104] Example 10
[0105] This embodiment provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects. The method is different from Embodiment 1 only in that in step (3), mannitol is replaced by sucrose in equal amounts, and other operations remain unchanged.
[0106] Comparative Example 1
[0107] This comparative example provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The difference between the method and Example 1 is that step (4) is to "inoculate 8% of Bifidobacterium breve ATCC 15700 bacterial solution (the number of viable bacteria is 3×10 6 CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, fermentation was carried out at 34 °C, 80 rpm for 14 h, the pH was adjusted to 5.5, and the first fermentation product was obtained". Other operations remained unchanged.
[0108] Comparative Example 2
[0109] This comparative example provides a method for preparing an Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects. The difference between the method and Example 1 is that step (4) is to inoculate 8% of the bacterial solution of Saccharomyces cerevisiae YK-S001 (the number of viable bacteria is 3×10 6 CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, fermentation was carried out at 34 °C, 80 rpm for 14 h, the pH was adjusted to 5.5, and the first fermentation product was obtained". Other operations remained unchanged.
[0110] Comparative Example 3
[0111] This comparative example provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects. The method differs from Example 1 only in that step (4) is not included, and other operations remain unchanged.
[0112] Comparative Example 4
[0113] This comparative example provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects. The method differs from Example 1 only in that step (5) is not included, and other operations remain unchanged.
[0114] Comparative Example 5
[0115] This comparative example provides a method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, the preparation method comprising:
[0116] (1) grinding a Chinese medicine composition into powder, wherein the Chinese medicine composition comprises 4 parts of Artemisia annua, 2 parts of Artemisia annua, 1 part of Portulaca oleracea, and 1 part of Sophora flavescens, adding 15 parts of water, and grinding using a colloid mill to obtain a slurry;
[0117] (2) heating the slurry to 45° C. and adding enzymes for hydrolysis for 1.5 h, wherein the enzymes are a combination of cellulase, pectinase, and protease with an enzyme activity ratio of 3:1:1 and a total enzyme activity of 80,000 U / g, to obtain an enzymatic hydrolyzate;
[0118] (3) Mix the enzymatic hydrolyzate with 80 parts of water, 1.5 parts of mannitol, 0.8 parts of inulin, 0.04 parts of magnesium sulfate, and 0.04 parts of potassium dihydrogen phosphate, adjust the pH to about 6.5, and sterilize at 121° C. for 20 minutes to prepare a fermentation medium;
[0119] (4) Inoculate 3% Bacillus subtilis ATCC6633 culture medium (viable cell count 3×10 7 CFU / mL), pH was adjusted to 6.2, at 35°C, with aeration of 15 m 3 / h for 24 h to obtain the first fermentation product;
[0120] (5) The first fermentation product was sterilized at 85°C for 20 min and inoculated with 4% Bifidobacterium breve ATCC 15700 culture medium (viable count 3×10 6 CFU / mL) and 4% Saccharomyces cerevisiae YK-S001 solution (viable count 3×10 6 CFU / mL), nitrogen was introduced, dissolved oxygen was set to 0%, fermentation was carried out at 34°C and 80 rpm for 14 h, and the pH was adjusted to 5.5 to obtain the second fermentation product;
[0121] (6) The obtained product was centrifuged at 9000 rpm for 5 min, and the supernatant was sterilized by filtering through 0.22 μm.
[0122] Test Example 1
[0123] In this test example, the appearance, odor, solid content, organic acid content, and polysaccharide content of the products obtained in Examples 1-3 were measured. The results are shown in Table 1.
[0124] Samples to be tested: Examples 1-3
[0125] (1) Solid content test: Weigh 2 g of the sample to be tested (m0=2) and dry it at 95°C for 120 min. Take it out and put it in a desiccator. After cooling to 25°C, weigh it as m1.
[0126] Solid content = (m1 / m0) × 100%
[0127] (2) Detection of organic acid content: The sample to be tested was diluted 5 times with deionized water, filtered with a 0.22 μm microporous filter membrane, and the organic acid content in the fermentation filtrate was determined by high performance liquid chromatography.
[0128] Chromatographic conditions:
[0129] The chromatographic column is Aminex@HPX-87H Exclusion Column (300mm×7.8mm);
[0130] The mobile phase is 0.275% (volume ratio) concentrated sulfuric acid solution;
[0131] The flow rate was 0.4 mL / min.
[0132] The column temperature was 40°C;
[0133] The injection volume was 10 μL;
[0134] The detection wavelength is 210 nm.
[0135] (3) Polysaccharide content detection: Spectrophotometry was used with a detection wavelength of 490 nm.
[0136] Table 1
[0137]
[0138] It can be seen from the data in Table 1 that the fermentation product obtained by the specific preparation process involved in the present invention has a high level of polyphenols, organic acids, flavonoids and polysaccharides, which provides a basis for its excellent antioxidant, anti-wrinkle, and allergy-relieving effects.
[0139] Test Example 2
[0140] (1) DPPH removal experiment
[0141] According to the "Cosmetics - Free Radical (DPPH) Scavenging Experimental Method (T / SHRH006-2018)", the DPPH free radical scavenging rate (%) of the products prepared in the above Examples 1-10 and Comparative Examples 1-5 and the blank control group was tested respectively.
[0142] Experimental method: A 96-well plate was used, with three replicate wells in each group and a system of 200 μL.
[0143] Sample group: The fermentation product was diluted in 100 μL of distilled water to make the final concentration of the sample in the system 10%, and 100 μL of 0.1 mM DPPH solution was added to the reaction system;
[0144] Control group: Take 100 μL of distilled water and add 100 μL of 0.1 mM DPPH solution.
[0145] After the reaction system was constructed, it was shaken in the dark for 10 min and the absorbance at 520 nm was measured using an ELISA reader.
[0146] Calculation method of clearance rate: Clearance rate (%) = [(A0-Ax) / A0] × 100%
[0147] A0 is the absorbance of the control group, and Ax is the absorbance of the sample group.
[0148] (2) Superoxide anion free radical scavenging experiment
[0149] Take 4.5 mL of Tris-HCl buffer solution in two groups (Group A is the sample to be tested, Group B is the blank control), place it in a 25℃ water bath for 20 min, and add 5 mL of ethanol aqueous solution of each group of freeze-dried products to Group A after the end of the insulation, and add 5 mL of ethanol aqueous solution to Group B as a blank control. Add 0.3 mL of pyrogallol solution to each group, shake it quickly and react for 4 min, then add 0.2 mL of HCl solution to terminate the reaction. Measure the absorbance at 325 nm to calculate the superoxide anion clearance, and the positive control is ascorbic acid.
[0150] Calculation method of clearance rate: Clearance rate (%) = [(ODB-ODA) / ODB] × 100%
[0151] Where ODB is the absorbance of the control group, and ODA is the absorbance of the sample solution.
[0152] (3) TNF-α inhibition experiment
[0153] Experimental method: RAW264.7 macrophages were used as the research object, and the cell inflammation model was established by stimulating the cells with lipopolysaccharide LPS (bacterial endotoxin). Macrophages were inoculated into 12-well plates and incubated in an incubator at 37°C and 5% CO2 ventilation for 24 h. 2% dilutions of the products of Examples 1-10 and Comparative Examples 1-5 were added respectively. LPS (1 μg / mL) was added after 2 h, and a group with no diluent and only LPS was added, and a group with no LPS and only diluent was set up. Stimulate for 24 h, collect the supernatant, centrifuge, and detect. The release level of the pro-inflammatory inflammatory factor TNF-α of RAW264.7 was analyzed using an ELISA kit.
[0154] The TNF-α inhibition rate was calculated by the following formula:
[0155] TNF-α inhibition rate (%) = [(inflammatory factor concentration in LPS stimulation group - inflammatory factor concentration in test substance action group) / (inflammatory factor concentration in LPS stimulation group - inflammatory factor concentration in unstimulated group)] × 100%
[0156] The above results are shown in Table 2.
[0157] Table 2
[0158]
[0159] As can be seen from the data in Table 2, the fermentation product obtained by the method of the present invention has good antioxidant and soothing effects, and the mixed fermentation effect of several traditional Chinese medicines is better than the fermentation without one of them. Moreover, Bifidobacterium breve and Saccharomyces cerevisiae can cooperate with each other, and the fermentation effect of adding both at the same time is better. The two-step fermentation effect is better than the one-step fermentation.
[0160] Test Example 3
[0161] Antibacterial effect
[0162] Preparation of bacterial solution: Use sterile saline to dilute Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Malassezia furfur to a viable count of about 1×10 6 The prepared bacterial suspension should be used within 2 hours or stored at 2-8℃ for no more than 24 hours.
[0163] Antibacterial effect detection: Take the fermented products obtained in the examples and comparative examples, take sterile dry filter paper pieces, and add 20 μL of an aqueous solution of the composition at an actual concentration (10 mg / mL) to each piece.
[0164] Test bacteria inoculation: Take 1mL of each test bacteria suspension and spread it evenly on the surface of the nutrient agar medium; paste the antibacterial test sample, and paste a contaminated plate for each test. There are 4 filter paper sheets per dish, 3 test sheets, and 1 control sheet as a blank. Use sterile tweezers to paste the sample sheet on the surface of the plate, place it in a constant temperature incubator at 36±1℃, observe the results after culturing for 18 hours, and measure the diameter of the antibacterial ring with a vernier caliper. The result is the average of 3 measurement data, and no antibacterial ring is produced in the control group.
[0165] Table 3
[0166]
[0167] As can be seen from the data in Table 3, the fermentation product obtained by the method of the present invention has a good antibacterial effect, and the mixed fermentation effect of several traditional Chinese medicines is better than the fermentation without one of them. Moreover, Bifidobacterium breve and Saccharomyces cerevisiae can cooperate with each other, and the fermentation effect of adding both at the same time is better. The two-step fermentation effect is better than the one-step fermentation.
[0168] Test Example 4
[0169] Oil control effect test
[0170] Test method:
[0171] (1) Preparation of reagents:
[0172] Testosterone (T) solution: dissolve testosterone in anhydrous ethanol to obtain a testosterone solution with a concentration of 5 mmol / L;
[0173] NADPH solution: Dissolve NADPH tetrasodium salt in water to obtain a 2 mmol / L NADPH solution;
[0174] Reaction solution: Dissolve DTT and sodium phosphate in water to make the final concentrations of DTT and sodium phosphate 1 mmol / L and 20 mmol / L, respectively, to obtain a reaction solution.
[0175] (2) Determination of 5α-reductase activity:
[0176] The reaction components were mixed in order (reaction solution 155 μL, constant temperature 37°C; testosterone solution 10 μL; NADPH solution 10 μL; 5α-reductase 20 μL), and the absorbance change of the reaction system at 340 nm was continuously monitored within 4 min. The rate of change reflected the activity of 5α-reductase (in the reaction system at a temperature of 37°C, the amount of enzyme that causes the NADPH concentration to decrease by 1 μmol / L per minute is one enzyme activity unit), which was recorded as the initial enzyme activity.
[0177] (3) Determination of 5α-reductase inhibition rate of the product:
[0178] The reaction components were mixed in order (reaction solution 155 μL, constant temperature 37 °C; testosterone solution 10 μL; NADPH solution 10 μL; 15 μL of the product of the embodiment and the comparative example respectively; 5α-reductase 20 μL), and the change of the absorbance value of the reaction system at 340 nm was continuously monitored within 4 min. The enzyme activity of 5α-reductase inactivation was calculated with reference to the NADPH standard curve, and the 5α-reductase inhibition rate was calculated. The results are shown in Table 4.
[0179] 5α-reductase inhibition rate (%) = inactivated enzyme activity / initial enzyme activity × 100%
[0180] Table 4
[0181]
[0182] 5α-reductase is an important metabolic enzyme in the skin that can convert testosterone into dihydrotestosterone, which can induce excessive oil secretion from the sebaceous glands. Therefore, the 5α-reductase activity inhibition rate can be tested to determine whether the test substance has the ability to relieve excessive oil secretion from the sebaceous glands. The higher the 5α-reductase inhibition rate, the better the oil control effect of the sample.
[0183] Test Example 5
[0184] Safety Test
[0185] Test method: Select a qualified patch tester and use the closed patch test method. Add 0.020g-0.025g of the test substance into the patch tester. The control group is applied with special external tape on the back of the test subject. Remove the test substance after 24 hours, observe the skin reaction 0.5, 24, and 48 hours after removal, and record the results according to the skin grading standards in the "Technical Specification for Safety of Cosmetics" (2015 edition).
[0186] Table 5
[0187]
[0188] Table 6
[0189]
[0190] The applicant declares that the present invention illustrates the preparation method of the fermented Artemisia annua product with soothing, oil-controlling and antibacterial effects, its product and application through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, the equivalent replacement of the raw materials of the product of the present invention, the addition of auxiliary components, the selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
[0191] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
[0192] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.
Claims
1. A method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects, characterized in that: The preparation method comprises: (1) inoculating a culture medium containing Artemisia annua with a culture medium containing Bifidobacterium breve and a culture medium containing Saccharomyces cerevisiae, and fermenting the culture medium to obtain a first fermentation product; (2) sterilizing the first fermentation product, cooling it, inoculating it with a Bacillus subtilis solution, and fermenting it to obtain a second fermentation product; (3) Centrifuging and sterilizing the second fermentation product to obtain; The method for preparing the culture medium containing Artemisia annua comprises: (1) Grind 3-5 parts of Artemisia annua, 1-3 parts of Artemisia annua, 1-2 parts of Portulaca oleracea, and 1-2 parts of Sophora flavescens, mix and grind with 10-15 parts of water to obtain a slurry; (2) enzymatically hydrolyzing the slurry to obtain an enzymatic hydrolysate; (3) Mix the enzymatic hydrolysate with 0.2-2.5 parts of a carbon source, 0.05-0.1 parts of an inorganic salt, 0.5-1 parts of inulin, and 70-80 parts of water, and sterilize to obtain the product; The carbon source includes mannitol, and the inorganic salt includes potassium dihydrogen phosphate and magnesium sulfate.
2. The method for preparing the Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects according to claim 1, characterized in that: The number of viable bacteria in the brewer's yeast solution is (1×10 6 ) CFU / mL-(5×10 6 ) CFU / mL, and the inoculum size was 3-5%.
3. The method for preparing the Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects according to claim 1, characterized in that: The number of viable bacteria in the Bifidobacterium breve bacterial solution is (1×10 6 )CFU / mL-(5×10 6 ) CFU / mL, and the inoculum size was 3-5%.
4. The method for preparing the Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects according to claim 1, characterized in that: The number of viable bacteria in the Bacillus subtilis liquid is (1×10 7 ) CFU / mL-(5×10 7 ) CFU / mL, and the inoculum size was 2-4%.
5. The method for preparing the Artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects according to claim 1, characterized in that: In step (1), the fermentation temperature is 30-35°C, the fermentation time is 12-16 h, and the pH is 5-6.
6. The method for preparing the artemisia annua fermentation product with soothing, oil-controlling and antibacterial effects according to claim 1, characterized in that: In step (2), the fermentation temperature is 35-36°C, the fermentation time is 20-28 h, and the pH is 6-6.
5.
7. An Artemisia annua fermentation product prepared by the method for preparing an Artemisia annua fermentation product having soothing, oil-controlling and antibacterial effects according to any one of claims 1 to 6.
8. Use of the Artemisia annua fermentation product according to claim 7 in the preparation of cosmetics.
Citation Information
Cited By
Artemisia annua fermented milk with effects of controlling oil, removing acne and resisting inflammation as well as preparation method and application of artemisia annua fermented milk
CN122272436A
